Predictors of in-hospital delay to reperfusion in patients with acute myocardial infarction in Japan

Journal of Emergency Medicine

Volumn 31, Issue 3, 2006, Pages 241-245

  Fukuoka, Yoshimi ^a   Dracup, Kathleen ^a   Ohno, Miyoshi ^b   Kobayashi, Fumio ^c   Hirayama, Haruo ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^c AICHI MEDICAL UNIVERSITY   (Japan)

^d NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

Author keywords

acute myocardial infarction; chest pain; diaphoresis; door to needle time; emergency medical services; in hospital delay; Japan, ambulance; public education

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; AMBULANCE; ARTICLE; DISEASE SEVERITY; EMERGENCY HEALTH SERVICE; FEMALE; HEART CATHETERIZATION; HEART MUSCLE REPERFUSION; HOSPITAL ADMISSION; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PATIENT TRANSPORT; PREDICTION; PRIORITY JOURNAL; SYMPTOMATOLOGY; TIME;

AGED; AMBULANCES; ANGIOPLASTY, BALLOON, CORONARY; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; EMERGENCY TREATMENT; FEMALE; HEART CATHETERIZATION; HUMANS; JAPAN; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT ADMISSION; THROMBOLYTIC THERAPY; TIME FACTORS; TRANSPORTATION OF PATIENTS;

EID: 33748530620     PISSN: 07364679     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jemermed.2005.12.019     Document Type: Article

References (20)

1. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 343 (1994) 311-322
2. GUSTO I. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 329 (1993) 673-682
3. Weaver W.D. Time to thrombolytic treatment: factors affecting delay and their influence on outcome. J Am Coll Cardiol 25 (1995) 3S-9S
4. Canto J.G., Zalenski R.J., Ornato J.P., et al. Use of emergency medical services in acute myocardial infarction and subsequent quality of care: observations from the National Registry of Myocardial Infarction 2. Circulation 106 (2002) 3018-3023
5. Brodie B.R., Stuckey T.D., Hansen C.J., et al. Effect of treatment delay on outcomes in patients with acute myocardial infarction transferred from community hospitals for primary percutaneous coronary intervention. Am J Cardiol 89 (2002) 1243-1247
6. De Luca G., Suryapranata H., Zijlstra F., et al. Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty. J Am Coll Cardiol 42 (2003) 991-997
7. Angeja B.G., Gibson C.M., Chin R., et al. Predictors of door-to-balloon delay in primary angioplasty. Am J Cardiol 89 (2002) 1156-1161
8. Goldberg R.J., Steg P.G., Sadiq I., et al. Extent of, and factors associated with, delay to hospital presentation in patients with acute coronary disease (the GRACE registry). Am J Cardiol 89 (2002) 791-796
9. Watanabe I., Kanmatsuse K., Ishikawa K., Kodama K., Sumiyoshi T., and Takeshita A. Current Japanese strategy to AMI. J Jpn Coron Assoc 7 (2001) 14-18
10. Nishigaki K., Yamazaki T., Fukunishi M., Tanihata S., and Fujiwara H. Assessment of acute myocardial infarction in Japan by the Japanese Coronary Intervention Study (JCIS) Group. Circ J 68 (2004) 515-519
11. Fukuoka Y., Dracup K., Kobayashi F., et al. Trajectory of prehospital delay in patients with acute myocardial infarction in the Japanese health care system. Int J Cardiol 107 (2006) 188-193
12. Fukuoka Y., Dracup K., Kobayashi F., et al. Illness attribution among Japanese patients with acute myocardial infarction. Heart Lung 33 (2004) 146-153
13. Okuda J., Kimura K., Kosuge M., et al. Significance of thrombolysis in myocardial infarction (TIMI) grade 2 flow early after thrombolysis followed by immediate percutaneous coronary intervention in patients with acute myocardial infarction. Circ J 67 (2003) 238-242
14. Nagao K., Hayashi N., Kanmatsuse K., et al. An early and complete reperfusion strategy for acute myocardial infarction using fibrinolysis and subsequent transluminal therapy-The FAST trial. Circ J 66 (2002) 576-582
15. Moon J.C., Kalra P.R., and Coats A.J. DANAMI-2: is primary angioplasty superior to thrombolysis in acute MI when the patient has to be transferred to an invasive centre?. Int J Cardiol 85 (2002) 199-201
16. Nakamura I., Hori S., Suzuki M., et al. Critical pathway improves arrival-in-cath-lab interval for patients with acute myocardial infarction in the emergency department. Jpn Circ J 65 (2001) 849-852
17. Shry E.A., Eckart R.E., Winslow J.B., Rollefson W.A., and Simpson D.E. Effect of monitoring of physician performance on door-to-balloon time for primary angioplasty in acute myocardial infarction. Am J Cardiol 91 (2003) 867-869
18. Ward M.R., Lo S.T., Herity N.A., Lee D.P., and Yeung A.C. Effect of audit on door-to-inflation times in primary angioplasty/stenting for acute myocardial infarction. Am J Cardiol 87 (2001) 336-338 A9
19. Cannon C.P., Gibson C.M., Lambrew C.T., et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA 283 (2000) 2941-2947
20. Brieger D., Eagle K.A., Goodman S.G., et al. Acute coronary syndromes without chest pain, an underdiagnosed and undertreated high-risk group: insights from the Global Registry of Acute Coronary Events. Chest 126 (2004) 461-469